Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource  rightarrow Blog  rightarrow C12orf29 sirna  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
separator
 • anti-CD42b antibody blog
 • hsa-miR-328-3p mirna blog
 • Bladder lysate blog
 • UBE2Q1 sirna blog
 • AQP7 sirna blog
 • anti-EIF2AK3 antibody blog
 • anti-CSNK2A1 antibody blog
 • Stugeron inhibitor blog
 • anti-Creatine Kinase MB (CK-MB) antibody blog
 • EPHB3 blocking peptide blog
 • IL-6 elispot kit blog
 • SSBP2 peptide blog
 • IL-8 elisa kit blog
 • Adrenaline ria kit blog
 • SLAMF8 sirna blog
 • H5 recombinant protein blog
 • anti-ALB antibody blog
 • anti-Ractopamine (10') antibody blog
 • anti-AKAP8L antibody blog
 • Fmoc-D-Lys(Boc)-OH amino acid blog
separator
Blog Categories separator
separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
separator
Our Best Sellers moreseparator
separator
 • Actin alpha 2, aortic smooth muscle (Acta2-Actsa-Actvs) ELISA Kit
 • membrane-associated ring finger (C3HC4) 7 (MARCH7) ELISA Kit
 • Tubulin Beta 3 (TUBb3) ELISA Kit
 • GRM1 Antibody
 • CRISPLD2 Antibody
 • acyl-CoA synthetase long-chain family member 6 (ACSL6) ELISA Kit
 downarrow more ...
separator

C12orf29 sirna product blog

separator
Posted on 2017-04-27 02:27:06 by mybiosource_staff
Share it on ...     
separator
separator
Tags: siRNA; C12orf29; C12orf29 sirna;
separator
The C12orf29 c12orf29 (Catalog #MBS8211714) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The C12orf29 siRNA (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s C12orf29 can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the C12orf29 c12orf29 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The C12orf29 c12orf29 product has the following accession number(s) (GI #61742164) (NCBI Accession #NP_001009894.2) (Uniprot Accession #Q8N999). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:


siRNA to inhibit C12orf29 expression using RNA interference.

C12orf29 c12orf29

Quality Control: Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use: We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components: We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human C12orf29 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2\'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions